Study examines Global Fund's resource allocation decisions for HIV programs

NewsGuard 100/100 Score

study published Wednesday in the Journal of the International AIDS Society assessed how the Global Fund to Fight AIDS, Tuberculosis and Malaria's "investments in HIV programs were targeted to key populations in relation to disease burden and national income," concluding, "There has been a sustained scale up of the Global Fund's support to HIV programs. Funding has targeted the countries and populations with higher HIV burden and lower income. Prevention in most-at-risk populations is not adequately prioritized in most of the recipient countries. In response, the Global Fund Board has recently modified eligibility and prioritization criteria to better target most-at-risk populations in Round 10 and beyond" (Avdeeva et al., 10/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Increased coronary vessel wall thickness linked to heart dysfunction in asymptomatic HIV patients